Future Pharmacology

25/11/2025

24/11/2025

Professor DiMarchi discusses his career, advice for young scholars, and what being a co-recipient of the 2024 Tu Youyou Award means to him.

21/11/2025

📢 We are delighted to announce that Prof. Dr. Wen Liu from Shanghai Institute of Organic Chemistry, China, will serve as a Keynote Speaker for the session on “Biocatalysis for Natural Product and Drug Synthesis” at the 5th Medicinal Chemistry Symposium ( ): New Trends in Chemical Biology and Drug Discovery, which will be held in , China, from May 14 to 17, 2026.

🎤 Prof. Liu is a Professor at the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, CAS / 中国科学院 / 중국과학원. His research focuses on the biosynthesis of natural products, including the establishment of metabolic pathways, elucidation of novel enzymatic mechanisms, and key scientific theories and methodologies for the industrialization of bulk antibiotic products.

✨ Don't miss the opportunity to interact with Prof. Liu!
📝 Submit your abstracts here: https://brnw.ch/21wXCXu

20/11/2025

⏰ Deadline Approaching!

🖊️ Submit your work to our Special Issue 'Transdiagnostic Psychopharmacology: Bridging Mechanisms Across Mental Disorders,' before the deadline!

👨‍🔬 Guest Editor: Prof. Dr. Felix Kessler
🏫 Federal University of Rio Grande do Sul

🔗 https://brnw.ch/21wXGmP

20/11/2025

19/11/2025

With the growing demand for Open Access globally, MDPI's Institutional Open Access Program (IOAP) makes publishing more accessible through flexible discount and flat-fee agreements for member institutions.

Each year, institutions and their researchers save millions through APC discounts, ensuring that new research is freely accessible to all.

Find out more about IOAP 👇

https://brnw.ch/21wXAH0

19/11/2025

🚨Attendees of will receive a 20% discount on the publication fees for the conference’s , open for submissions until 31 August 2026 📝

This preferential rate only applies to attendees with a completed registration to the conference, so don't miss the opportunity to broaden your reach by also sharing your findings in the journal Antibiotics after the event – register at https://brnw.ch/21wV7eQ today ⬅️

14/11/2025

🚀 We are thrilled to be part of the British Pharmacological Society’s annual Pharmacology 2025 conference, and our delegates are eager to meet you at booth #12.

📅 16–18 December 2025
📌 Belfast, UK

We can’t wait to share the exciting advancements we’re working on!

For more details, please check the website:
https://brnw.ch/21wXylS

12/11/2025

🔔 Announcement

We’re pleased to share that Future Pharmacology will be granting the to one outstanding junior scientist!

🗓️ Application period: November 2025 – May 2026
🏆 Winner announcement: July 2026

Learn more about the award and how to apply here 👉
https://brnw.ch/21wXyjH

👏 Don’t miss this opportunity to celebrate innovation in pharmacology!

10/11/2025

📢 We are delighted to announce that Prof. Dr. Christophe Rochais from Université de Caen Normandie (University of Caen Normandy), France, will serve as a Keynote Speaker for the session on “Drug Discovery Targeting GPCRs and Ion Channels” at the 5th Medicinal Chemistry Symposium ( ): New Trends in Chemical Biology and Drug Discovery, which will be held in , China, from May 14 to 17, 2026.

🎤 Prof. Christophe Rochais is a professor in organic chemistry at the University of Caen Normandy, and a member of the French National Academy of Pharmacy. His research interests include medicinal chemistry programs in the field of enzymatic inhibition and receptor modulation, aiming to develop pharmacological tools and bioactive compounds. He leads a research group dedicated to developing polypharmacology approaches for the treatment of neurodegenerative and infectious diseases.

✨ Don't miss the opportunity to interact with Prof. Christophe Rochais!
📝 Submit your abstracts here: https://brnw.ch/21wXdJE

07/11/2025

📢 Most Cited & Viewed Papers Alert!

Decoding Anticancer Drug Response: Comparison of Data-Driven and Pathway-Guided Prediction Models 💊

Background/Objective: Predicting pharmacological response in cancer remains a key challenge in precision oncology due to intertumoral heterogeneity and the complexity of drug–gene interactions.

06/11/2025

📢 Most Cited & Viewed Papers Alert!

Effects of Tyrphostin A9 and Structurally Related Tyrphostins on Colorectal Carcinoma Cells 💊

Background/Objectives: Colorectal carcinoma (CRC) is among the most commonly diagnosed cancers in both men and women. Although CRC mortality is generally decreasing, new therapeutic options are needed for unresponsive subgroups of CRC patients. Methods: A series of known and new tyrphostin derivativ...